{"changes":[{"companyHref":"/c/entelexo-com","date":"2026-10-03","documentUrl":"https://www.ycombinator.com/companies/entelexo-biotherapeutics","domain":"entelexo.com","fact":"company:added","name":"Entelexo Biotherapeutics","new":"added","old":"","publisher":"Y Combinator","reason":null,"retrievedAt":"2026-10-03","slug":"entelexo-com","status":"sourced","url":"https://whoraisedwhat.com/c/entelexo-com"}],"country":"","description":"Creating a New Class of Drugs to Address Incurable Autoimmune Diseases","domain":"entelexo.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","investors":[],"lat":null,"lng":null,"location":"Irvine, CA","name":"Entelexo Biotherapeutics","people":[],"rounds":[],"slug":"entelexo-com","sources":[{"fact":"existence","publisher":"Y Combinator","retrievedAt":"2026-10-03","status":"sourced","url":"https://www.ycombinator.com/companies/entelexo-biotherapeutics"},{"fact":"description","publisher":"Y Combinator","retrievedAt":"2026-10-03","status":"sourced","url":"https://www.ycombinator.com/companies/entelexo-biotherapeutics"}],"stage":null,"techStack":[],"totalRaisedUsd":null,"updatedAt":"2026-10-03"}